News
Genmab plunges after financial report: Analyst cites uncertainty surrounding clinical trials
1+ hour, 1+ min ago (158+ words) medwatch. com Stay ahead of development by receiving our newsletter on the latest sector knowledge. Genmab plunges after financial report: Analyst cites uncertainty surrounding clinical trials Analysts estimate the drop in the stock price is due to uncertainty about the…...
Leo Pharma climbs up from bottom ranks but remains among companies with worst reputations
1+ hour, 46+ min ago (201+ words) medwatch. com Stay ahead of development by receiving our newsletter on the latest sector knowledge. Leo Pharma climbs up from bottom ranks but remains among companies with worst reputations Despite an improved reputation in life sciences, Leo Pharma is still…...
Novo's Ozempic tablet will be added to Amazon's product lineup
2+ hour, 27+ min ago (180+ words) medwatch. com Stay ahead of development by receiving our newsletter on the latest sector knowledge. Clinical Trial Assistant (CTA) Novo's Ozempic tablet will be added to Amazon's product lineup Amazon also plans to add Eli Lilly's weight-loss pill, Foundayo " a…...
The Lundbeck Foundation cuts DKK 500 million from Danish pharmaceutical supplier: "It's shaping up to be quite a thriller
3+ hour, 55+ min ago (181+ words) medwatch. com Stay ahead of development by receiving our newsletter on the latest sector knowledge. The Lundbeck Foundation cuts DKK 500 million from Danish pharmaceutical supplier: "It's shaping up to be quite a thriller" Three years after acquiring Ellab, the Lundbeck…...
EU reaches preliminary AI agreement: Industry lobby calls it "major own goal"
3+ hour, 38+ min ago (179+ words) medwatch. com Stay ahead of development by receiving our newsletter on the latest sector knowledge. EU reaches preliminary AI agreement: Industry lobby calls it "major own goal" The deal is meant simplify and harmonize AI regulations, but it could create…...
Wegovy pill gaining ground in new prescriptions
4+ hour, 15+ min ago (146+ words) medwatch. com Stay ahead of development by receiving our newsletter on the latest sector knowledge. Wegovy pill gaining ground in new prescriptions Eli Lilly also saw growth. Novo Nordisk's Wegovy pill continues to gain ground in the US, with more…...
Genmab maintains guidance following quarterly results
3+ hour, 43+ min ago (94+ words) Genmab is maintaining its 2026 guidance, according to its quarterly report. Genmab expects 2026 revenue of USD 4, 0654, 395m and operating profit of USD 9001, 400m. Sales of Darzalex by partner Johnson & Johnson are still expected to reach USD 15. 616. 4bn this year, and Genmab expects royalty revenue…...
Novo Nordisk does not expect the Chinese patent for semaglutide to expire until 2027
4+ hour, 14+ min ago (45+ words) medwatch. com Novo Nordisk does not expect the patent for semaglutide, the active ingredient in Wegovy and Ozempic, to expire in the Chinese market until 2027, as reported by Bloomberg News....
New report: Trump's push to lower drug prices could cut USD 529bn from state spending
5+ hour, 17+ min ago (202+ words) medwatch. com Stay ahead of development by receiving our newsletter on the latest sector knowledge. New report: Trump's push to lower drug prices could cut USD 529bn from state spending According to the White House, the US stands to realize significant…...
Genmab is ahead of schedule " sees potential for launches in 2027
4+ hour, 59+ min ago (502+ words) Another link has been added to the chain of key data sets for Genmab this year. The biotech company now expects to present up to seven data sets this year, which, if all goes well, could enable product launches as…...